Cargando…
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
SARS-CoV-2 Omicron infections are common among individuals who are vaccinated or have recovered from prior variant infection, but few reports have immunologically assessed serial Omicron infections. We characterized SARS-CoV-2 humoral responses in an individual who acquired laboratory-confirmed Omic...
Autores principales: | Lapointe, Hope R., Mwimanzi, Francis, Cheung, Peter K., Sang, Yurou, Yaseen, Fatima, Kalikawe, Rebecca, Datwani, Sneha, Waterworth, Rachel, Umviligihozo, Gisele, Ennis, Siobhan, Young, Landon, Dong, Winnie, Kirkby, Don, Burns, Laura, Leung, Victor, Holmes, Daniel T., DeMarco, Mari L., Simons, Janet, Matic, Nancy, Montaner, Julio S.G., Brumme, Chanson J., Prystajecky, Natalie, Niikura, Masahiro, Lowe, Christopher F., Romney, Marc G., Brockman, Mark A., Brumme, Zabrina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485663/ https://www.ncbi.nlm.nih.gov/pubmed/36148225 http://dx.doi.org/10.3389/fimmu.2022.947021 |
Ejemplares similares
-
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023) -
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
por: Brockman, Mark A., et al.
Publicado: (2021) -
Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose
por: Mwimanzi, Francis, et al.
Publicado: (2022) -
Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults
por: Datwani, Sneha, et al.
Publicado: (2023) -
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose( )
por: Mwimanzi, Francis, et al.
Publicado: (2022)